期刊名称：JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The official journal of the American College of Cardiology and the leader in its field, JACC publishes original peer-reviewed clinical and experimental reports on all aspects of cardiovascular disease. Topics covered include coronary artery and valve disease, congenital heart defects, vascular surgery, cardiomyopathy, drug treatment, new diagnostic techniques, findings from the laboratory, and large multicenter studies of new therapies. Symposia, clinical reviews and updates, editorial commentary, and letters are regular features.
JACC also publishes abstracts of papers presented at the annual scientific sessions of the American College of Cardiology and the reports and recommendations of the Bethesda Conferences on current topics in cardiovascular disease.
|
|
Instructions to Authors
The Journal of the American College of Cardiology (JACC) publishes peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, experimental investigations with clear clinical relevance, state-of-the-art papers, and viewpoints. In general, case reports will not be considered for publication.
We recommend that all manuscripts be submitted online at www.jaccsubmit.org. If the manuscript must be submitted in print, it should be addressed to: Anthony N. DeMaria, MD, MACC, Editor-in-Chief, Journal of the American College of Cardiology, 3655 Nobel Drive, Suite 400, San Diego, CA 92122. Please see General Guidelines below.
Authors in Japan please note: upon request, Elsevier Japan K.K. will provide authors with a list of people who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier Japan K.K., 1-9-15, Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan. Tel: (03) 5561 5032; Fax: (03) 5561 5045.
EXCLUSIVE SUBMISSION/PUBLICATION POLICY
Manuscripts are considered for review only under the conditions that they are not under consideration elsewhere and that the data presented have not appeared on the internet or have not been previously published (including symposia, proceedings, transactions, books, articles published by invitation and preliminary publications of any kind except abstracts not exceeding 400 words). On acceptance, written transfer of copyright to the American College of Cardiology Foundation, signed by all authors, will be required. Elsevier Inc. will maintain copyright records for the College.
PERMISSIONS
No part of materials published in JACC may be reproduced without written permission of the publisher. Address permission requests to Elsevier Inc. Global Rights Department, PO Box 800, Oxford OX5 1DX, UK. Fax: 44-1865-853-333; E-mail: permissions@elsevier.co.uk. You may also contact Global Rights directly through Elsevier's homepage (http://www.elsevier.com), by selecting "Obtaining Permissions" in customer support.
CONFLICT OF INTEREST POLICY
The Editors require authors to disclose any financial associations that might pose a conflict of interest in connection with the submitted article. All sources of funding for the work should be acknowledged in a footnote on the title page, as should all institutional affiliations of the authors (including corporate appointments). Other kinds of associations, such as consultancies, stock ownership or other equity interests or patent-licensing arrangements, should be disclosed to the Editors in the cover letter at the time of submission. If no conflict of interest exists, please state this in the cover letter and on the title page. Conflict of interest guidelines apply to authors of all of the following: Original Research Papers, State-of-the-Art Papers, Express Publications, Editorials and Viewpoints, Editorial Comments, and Letters to the Editor.
ETHICS
Studies should be in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines.
Human studies must be performed with the subjects' written informed consent. Authors must provide the details of this procedure and indicate that the institutional committee on human research has approved the study protocol. If radiation is used in a research procedure, the radiation exposure must be specified in the Methods.
Animal investigation must conform to the "Position of the American Heart Association on Research Animal Use," adopted by the AHA on November 11, 1984. If equivalent guidelines are used, they should be indicated. The AHA position includes: 1) animal care and use by qualified individuals, supervised by veterinarians, and all facilities and transportation must comply with current legal requirements and guidelines; 2) research involving animals should be done only when alternative methods to yield needed information are not possible; 3) anesthesia must be used in all surgical interventions, all unnecessary suffering should be avoided and research must be terminated if unnecessary pain or fear results; 4) animal facilities must meet the standards of the American Association for Accreditation of Laboratory Animal Care (AAALAC).
AUTHORSHIP/COVER LETTER
Each author must have contributed significantly to the submitted work. If there are more than 4 authors, the contribution of each must be substantiated in the cover letter. If authorship is attributed to a group (either solely or in addition to 1 or more individual authors), all members of the group must meet the full criteria and requirements for authorship. To save space, if group members have been listed in JACC, the article should be referenced rather than reprinting the list. The Editors consider authorship to include all of the following: 1) conception and design or analysis and interpretation of data, or both; 2) drafting of the manuscript or revising it critically for important intellectual content; and 3) final approval of the manuscript submitted. Participation solely in the collection of data does not justify authorship but may be appropriately acknowledged in the Acknowledgment section. Manuscripts must be submitted with a cover letter stating that 1) the paper is not under consideration elsewhere, 2) none of the paper's contents have been previously published, 3) all authors have read and approved the manuscript, and 4) the full disclosure of any potential conflict of interest (see Conflict of Interest Policy). Exceptions must be explained. The corresponding author should be specified in the cover letter. All editorial communications will be sent to this author.
GENERAL GUIDELINES FOR SUBMISSION OF ORIGINAL RESEARCH PAPERS
Because of printed page limitations, the Editors require that manuscripts not exceed 5,000 words (exclusive of references). Illustrations and tables should be limited to those necessary to highlight key data.
The manuscript should be arranged as follows: 1) title page, 2) structured abstract and key words, 3) condensed abstract, 4) abbreviations list, 5) text, 6) acknowledgments (if applicable), 7) references, 8) figure legends, 9) tables. Page numbering should begin with the title page.
OTHER PAPER CATEGORIES
The following information should be noted for these paper types:
State-of-the-Art Papers. The Editors will consider both invited and uninvited review articles. Such manuscripts must adhere to preferred length guidelines and require an unstructured abstract of no more than 250 words. Authors should detail in their cover letters how their submission differs from existing reviews on the subject.
Express Publications. Manuscripts in this category should report important original findings of high-potential clinical impact or research significance. It is recognized that the mechanisms, significance, and optimal application of these findings may not be fully defined. The manuscript should conform to the general guidelines for submission of original research papers, but should not exceed 2,500 words (exclusive of references) and illustrations and tables should be strictly limited to those necessary to highlight key data. For these submissions, the Editors commit to an initial decision within 14 days of receiving the manuscript, and print publication within six weeks of receiving the approved galley prints. Online publication will occur within 10 days of receiving the approved galley prints.
Expedited Review. Manuscripts in this category should report important original findings of high-potential clinical impact or research significance in a full-length paper. Authors must apply for expedited review consideration in their cover letter at the time of submission. The Editors commit to a decision regarding suitability for expedited review processing within five days, and an initial decision within 14 days. Those manuscripts not deemed appropriate for the expedited review track will be eligible for consideration according to the standard review process. Print publication of the manuscript will be accomplished within six weeks of receiving the approved galley proofs. Online publication will occur within 10 days of receiving the approved galley prints.
Editorials and Viewpoints. Succinct opinion pieces will also be considered. These papers should have a brief unstructured abstract.
Editorial Comments. The editors invite all Editorial Comments published in the Journal.
Letters to the Editor. A limited number of letters will be published. They should not exceed 500 words and should focus on a specific article appearing in JACC. No original data may be included. Type letters double-spaced and include the cited article as a reference. Provide a title page that includes authors' names and institutional affiliations and a complete address for correspondence. These can be submitted online at www.jaccsubmit.org. Replies will generally be solicited by the Editors.
FOR PRINT SUBMISSIONS
We strongly recommend that all manuscripts be submitted online at www.jaccsubmit.org. However, if the manuscript must be submitted in print, it should conform to the guidelines set forth in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," 5th edition, N Engl J Med 1997;336(4):309-15.
Along with a cover letter as outlined above, submit 2 complete copies of the manuscript, 2 sets of figures and tables, and 2 copies of the cover letter. Also include a disk, which should include the manuscript and cover letter in separate files. Figures and tables should be embedded in the manuscript, but they can also be included on the disk as separate files. We recommend the following figure formats: TIFF, JPEG, PDF, EPS, Postscript, CorelDraw, Adobe Photoshop. If supplementary materials such as "in press" references are included, provide 2 copies.
The manuscript should be typed double-spaced throughout, on one side only, on 22  28 cm (8.5 11") white bond paper with 3-cm margin on all sides (8-cm at bottom of title page). Please use a standard 10 cpi font or a laser printer font no smaller than 12 points.
TITLE PAGE
Include the title, authors' names (including full first name and middle initial, degrees and, where applicable, FACC), total word count and a brief title of no more than 45 characters. List the departments and institutions with which the authors are affiliated, and indicate the specific affiliations if the work is generated from more than one institution (use the footnote symbols given under "Tables"). Also provide information on grants, contracts and other forms of financial support, and list the cities and states of all foundations, funds and institutions involved in the work. Under the heading, "Address for correspondence," give the full name and complete postal address of the author to whom communications, printer's proofs and reprint requests should be sent. Also provide telephone and fax numbers and E-mail address.
STRUCTURED ABSTRACT
Provide a structured abstract of no more than 250 words, presenting essential data in five paragraphs introduced by separate headings in the following order: Objectives, Background, Methods, Results, Conclusions. Use complete sentences. All data in the abstract must also appear in the manuscript text or tables. For general information on preparing structured abstracts, see Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med 1990;113:69-76. A nonstructured abstract is appropriate for review articles.
CONDENSED ABSTRACT (for table of contents)
Provide a condensed abstract of no more than 100 words, stressing clinical implications, for the expanded table of contents. Include no data that do not also appear in the manuscript text or tables.
TEXT
To save space in the Journal, up to 10 abbreviations of common terms (e.g., ECG, PTCA, CABG) or acronyms (GUSTO, SOLVD, TIMI) may be used throughout the manuscript. On a separate page following the condensed abstract, list the selected abbreviations and their definitions (e.g., TEE = transesophageal echocardiography). The Editors will determine which lesser known terms should not be abbreviated. Consult "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," 5th edition, N Engl J Med 1997;336(4):309-15, for appropriate use of units of measure. Use headings and subheadings in the Methods, Results and, particularly, Discussion sections. Every reference, figure and table should be cited in the text in numerical order according to order of mention.
STATISTICS
All publishable manuscripts will be reviewed for appropriateness and accuracy of statistical methods and statistical interpretation of results. We subscribe to the statistics section of the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," 5th edition, N Engl J Med 1997;336:309-15. Provide in the Methods a subsection detailing the statistical methods, including specific methods used to summarize the data, methods used for hypothesis testing (if any) and the level of significance used for hypothesis testing. When using more sophisticated statistical methods (beyond t tests, chi-square, simple linear regression), specify the statistical package, version number and non-default options used. For more information on statistical review, see Glantz SA. It is all in the numbers. J Am Coll Cardiol 1993;21:835-7.
ACKNOWLEDGMENTS
Acknowledgments or appendices must contain 100 words or less. Anything exceeding this limit will appear in the online version only. Letters of permission from all individuals listed in the acknowledgment or appendix must be submitted to JACC.
REFERENCES
Identify references in the text by arabic numerals in parentheses on the line. The reference list should be typed double-spaced on pages separate from the text; references must be numbered consecutively in the order in which they are mentioned in the text.
Do not cite personal communications, manuscripts in preparation or other unpublished data in the references; these may be cited in the text in parentheses. Do not cite abstracts that are older than two years. Identify abstracts by the abbreviation "abstr" in parentheses. If letters to the editor are cited, identify them with the word "letter" in parentheses.
Use Index Medicus (National Library of Medicine) abbreviations for journal titles. Use the following style and punctuation for references:
Periodical
List all authors if six or fewer, otherwise list the first three and add the et al.; do not use periods after the authors' initials. Provide inclusive page numbers.
5. Glantz SA. It is all in the numbers. J Am Coll Cardiol 1993; 21:835-7.
Chapter in book
Provide inclusive page numbers, authors, chapter titles, book title, editor, publisher and year.
27. Meidell RS, Gerard RD, Sambrook JF. Molecular biology of thrombolytic agents. In: Roberts R, editor. Molecular Basis of Cardiology. Cambridge, MA: Blackwell Scientific Publications, 1993:295-324.
Book (personal author or authors)
Provide a specific (not inclusive) page number.
23. Cohn PF. Silent Myocardial Ischemia and Infarction. 3rd ed. New York, NY: Marcel Dekker, 1993:33.
FIGURE LEGENDS
Figure legends should be typed double-spaced on pages separate from the text; figure numbers must correspond with the order in which they are mentioned in the text.
All abbreviations used in the figure should be identified either after their first mention in the legend or in alphabetical order at the end of each legend. All symbols used (arrows, circles, etc.) must be explained.
If previously published figures are used, written permission from the original publisher and author is required. Cite the source of the figure in the legend.
FIGURES
We recommend the following figure formats: TIFF, JPEG, PDF, Postscript, CorelDraw, Adobe Photoshop. Lettering should be of sufficient size to be legible after reduction for publication. The optimal size is 12 points. Symbols should be of a similar size. Figures should be no smaller than 13 cm 18 cm (5" 7"). Please do not reduce figures to fit publication layout. If the manuscript is accepted for publication, the publisher will re-size the figures accordingly.
Upon Provisional Acceptance
We require 2 sets of glossy or laser prints (clean copies will suffice). Two sets of glossy prints should be provided for all half-tone or color illustrations. All graphs and line drawings must be professionally prepared on a computer and reproduced as high quality laser prints.
Decimals, lines and other details must be strong enough for reproduction. Use only black and white, not gray, in charts and graphs. Do not use 3-D presentations for bar graphs.
Place crop marks on photomicrographs to show only the essential field. Designate special features with arrows. All symbols, arrows and lettering on half-tone illustrations must contrast with the background.
Indicate the first author's last name (and the corresponding author's last name within parentheses, if different) and the figure number on the back of each figure, preferably on an adhesive label. Figure title and caption material must appear in the legend, not on the figure.
Note: the artwork of submitted articles will not be returned to authors.
Authors will bear the cost of reproducing color illustrations. The final bill for color costs will come from the publisher.
TABLES
Tables should be typed double-spaced on separate sheets, with the table number and title centered above the table and explanatory notes below the table. Use arabic numbers. Table numbers must correspond with the order cited in the text.
Abbreviations should be listed in a footnote under the table in alphabetical order. Footnote symbols should appear in the following order: *,  ,  , ¡ì,  ,  , #, **, , etc.
Tables should be self-explanatory, and the data presented in them should not be duplicated in the text or figures. If previously published tables are used, written permission from the original publisher and author is required. Cite the source of the table in the footnote.
VIDEO REQUIREMENTS
Inclusion of videos in the published paper is at the discretion of the Editors.
1. Video submissions for viewing on Cardiosource should be one of the following formats: Audio Video Interleave (.avi), MPEG (.mpg), or Quick Time (.qt, .mov).
AVI files can be displayed via Windows Media Player
http://www.microsoft.com/windows/windowsmedia/
http://www.microsoft.com/windows/windowsmedia/players.aspx
MPEG files can be displayed via Windows Media Player
Quick Time files require Quick Time software (free) from Apple.
http://www.apple.com/quicktime/download/index.html
2. Videos should be brief whenever possible (<2-5 minutes). Longer videos will require longer download times and may have difficulty playing online. Videos should be restricted to the most critical aspects of your research. A longer procedure can be restructured as several shorter videos and submitted in that form.
3. It is advisable to compress files to use as little bandwidth as possible and to avoid overly long download times. Video files should be no larger than 5 megabytes. This is a suggested maximum. If files are larger please contact the JACC office.
4. A caption giving a brief overall description of the video content should be provided for each video.
5. If your paper is accepted for publication you may wish to supply the editorial office with several different resolutions of your video files. This will allow viewers with slower connections to download a lower resolution version of your video.
Editorial Board
-
- EDITOR-IN-CHIEF
- A.N. DeMaria, MD, San Diego, CA, USA
- DEPUTY EDITOR
- O. Ben-Yehuda, MD, La Jolla, CA, USA
- ASSOCIATE EDITORS
- D. Berman, MD, Los Angeles, CA, USA
G.K. Feld, MD, San Diego, CA, USA
B.H. Greenberg, MD, San Diego, CA, USA
J.D. Knoke, PhD, San Diego, CA, USA
K.U. Knowlton, MD, La Jolla, CA, USA
W.Y.W. Lew, MD, La Jolla, CA, USA
S. Tsimikas, MD, San Diego, CA, USA
- MANAGING EDITOR
- G. Collins, San Diego, CA, USA
- SENIOR CONSULTING EDITORS
- K.R. Chien, MD, La Jolla, CA, USA
M.H. Criqui, MD, La Jolla, CA, USA
B.J. Gersh, MB, ChB, DPhil, Rochester, MN, USA
H.K. Hammond, MD, La Jolla, CA, USA
P. Insel, MD, La Jolla, CA, USA
S.W. Jamieson, MBBS, San Diego, CA, USA
S.E. Nissen, MD, Cleveland, OH, USA
A. Rothman, MD, La Jolla, CA, USA
L.J. Rubin, MD, San Diego, CA, USA
J. Witztum, MD, La Jolla, CA, USA
- SENIOR ADVISING EDITORS
- E. Braunwald, MD, Boston, MA, USA
T.P. Graham, Jr., MD, Nashville, TN, USA
R.H. Jones, MD, Durham, NC, USA
- IMMEDIATE PAST EDITOR-IN-CHIEF
- W.W. Parmley, MD, San Francisco, CA, USA
- FOUNDING EDITOR
- S. Dack, MD
- OFFICERS
- C.J. Pepine, MD, President
M.J. Wolk, MD, President-Elect
W.B. Fye, MD, MA, Immediate Past President
P.S. Douglas, MD, Vice President
A.S. Brown, MD, Secretary
J.T. Dove, MD, Treasurer
A.S. Brown, MD, Chair, Board of Governors
- PUBLICATIONS COMMITTEE
- E. Braunwald, MD, Chair
A.A. Bov¨¦, MD, PhD, (ex officio), Editor-in-Chief, Cardiosource
C.R. Conti, MD, (ex officio), Editor-in-Chief, ACCEL
A.N. DeMaria, MD, (ex officio), Editor-in-Chief, JACC
K.A. Eagle, MD, (ex officio), Editor-in-Chief, CJR
R.L. Frye, MD, (senior member)
R.L. Popp, MD, (senior member)
J. Loscalzo, MD, PhD
E.R. Passamani, MD
J.E. Udelson, MD
A.C. Yeung, MD
E.J. Wilson, ACC Staff
- EDITORIAL CONSULTANTS
- S. Achenbach, MD, Erlangen, Germany
H. Acquatella, MD, Miami, FL, USA
E.A. Amsterdam, MD, Sacramento, CA, USA
H.V. Anderson, MD, Houston, TX, USA
J.L. Anderson, MD, Salt Lake City, UT, USA
K.P. Anderson, MD, Marshfield, WI, USA
W.F. Armstrong, MD, Ann Arbor, MI, USA
G.P. Aurigemma, MD, Worcester, MA, USA
R.J. Bache, MD, Minneapolis, MN, USA
J.J. Badimon, PhD, New York, NY, USA
D.S. Baim, MD, Boston, MA, USA
H.V. Barron, MD, San Francisco, CA, USA
C.T. Basson, MD, PhD, New York, NY, USA
R.C. Becker, MD, Worcester, MA, USA
I. Belenkie, MD, CM, Calgary, Canada
D.G. Benditt, MD, Minneapolis, MN, USA
S. Beppu, MD, PhD, Suita-shi Osaka, Japan
M.E. Bertrand, MD, Lambersart, France
L.M. Biasucci, MD, Rome, Italy
V. Bittner, MD, Birmingham, AL, USA
W.E. Boden, MD, Hartford, CT, USA
J.A. Brinker, MD, Baltimore, MD, USA
B.R. Brodie, MD, Greensboro, NC, USA
L.M. Buja, MD, Houston, TX, USA
A.E. Buxton, MD, Providence, RI, USA
B.F. Byrd, III, MD, Nashville, TN, USA
M.E. Cain, MD, Saint Louis, MO, USA
R.M. Califf, MD, Durham, NC, USA
D. Celermajer, MD, Sydney, Australia
B.R. Chaitman, MD, Saint Louis, MO, USA
P.S. Chen, MD, Los Angeles, CA, USA
J.G.F. Cleland, MD, Cottingham, United Kingdom
L.H. Cohn, MD, Boston, MA, USA
A. Colombo, MD, Milan, Italy
C.R. Conti, MD, Gainesville, FL, USA
M.H. Crawford, MD, Scottsdale, AZ, USA
T. De Marco, MD, San Francisco, CA, USA
G.J. Dehmer, MD, Temple, TX, USA
E. DeLong, PhD, Durham, NC, USA
K.M. Detre, MD, DrPh, Pittsburgh, PA, USA
M.F. Di Carli, MD, Boston, MA, USA
P.S. Douglas, MD, Madison, WI, USA
H. Drexler, MD, Hannover, Germany
E.M. Dwyer, Jr., MD, Tenafly, NJ, USA
M.J. Eisenberg, MD, MPH, Montreal, Canada
K.A. Ellenbogen, MD, Richmond, VA, USA
L.M. Epstein, MD, Boston, MA, USA
D.P. Faxon, MD, Chicago, IL, USA
A.M. Feldman, MD, PhD, Philadelphia, PA, USA
M.S. Finkel, MD, Morgantown, WV, USA
D.J. Fitzgerald, MD, Dublin, Ireland
K.E. Fleischmann, MD, MPH, San Francisco, CA, USA
E. Foster, MD, San Francisco, CA, USA
J.A. Franciosa, MD, New York, NY, USA
G.S. Francis, MD, Cleveland, OH, USA
V.F. Froelicher, MD, Menlo Park, CA, USA
M.I. Furman, MD, Worcester, MA, USA
V. Fuster, MD, PhD, New York, NY, USA
W.H. Gaasch, MD, Auburndale, MA, USA
J.M. Gardin, MD, Detroit, MI, USA
M. Gheorghiade, MD, Chicago, IL, USA
R.J. Gibbons, MD, Rochester, MN, USA
C.M. Gibson, MD, Boston, MA, USA
J.A. Goldstein, MD, Royal Oak, MI, USA
S.S. Gottlieb, MD, Baltimore, MD, USA
P.A. Grayburn, MD, Dallas, TX, USA
C.L. Grines, MD, Royal Oak, MI, USA
P.A. Heidenreich, MD, Palo Alto, CA, USA
G.V. Heller, MD, PhD, Hartford, CT, USA
C.H. Hennekens, MD, Boca Raton, FL, USA
D.D. Hermann, MD, San Diego, CA, USA
G. Heusch, MD, Essen, Germany
M.A. Hlatky, MD, Palo Alto, CA, USA
B.D. Hoit, MD, Solon, OH, USA
D.R. Holmes, Jr., MD, Rochester, MN, USA
A.S. Jaffe, MD, Rochester, MN, USA
M.E. Josephson, MD, Boston, MA, USA
A.H. Kadish, MD, Chicago, IL, USA
J.M. Kalman, MBBS, PhD, Melbourne, Australia
K.R. Karsch, MD, Bristol, United Kingdom
S.B. King, III, MD, Atlanta, GA, USA
A. Kitabatake, MD, PhD, Sapporo-shi Hokkaido, Japan
N.S. Kleiman, MD, Houston, TX, USA
A.L. Klein, MD, CM, Cleveland, OH, USA
L.W. Klein, MD, Chicago, IL, USA
F.J. Klocke, MD, Chicago, IL, USA
R.A. Kloner, MD, PhD, Los Angeles, CA, USA
J.Y.T. Lam, MD, Montreal, Canada
C.V. Leier, MD, Columbus, OH, USA
A. Lerman, MD, Rochester, MN, USA
P. Libby, MD, Boston, MA, USA
J.R. Lindner, MD, Charlottesville, VA, USA
J. Loscalzo, MD, PhD, Boston, MA, USA
D.W. Losordo, MD, Boston, MA, USA
W.J. Manning, MD, Boston, MA, USA
F.E. Marchlinski, MD, Philadelphia, PA, USA
A.J. Marian, MD, Houston, TX, USA
J.D. Marmur, MD, New York, NY, USA
B.J. Maron, MD, Minneapolis, MN, USA
R.P. Martin, MD, Atlanta, GA, USA
A. Maseri, MD, Milan, Italy
B.M. Massie, MD, San Francisco, CA, USA
G. Maurer, MD, Wien, Austria
P.A. McCullough, MD, MPH, Northville, MI, USA
C.R. McKay, MD, Torrance, CA, USA
R.G. McKay, MD, Hartford, CT, USA
W.J. McKenna, MD, London, United Kingdom
M.R. Mehra, MBBS, New Orleans, LA, USA
J.V. Messer, MD, Glencoe, IL, USA
L. Mestroni MD, Aurora, CO, USA
R.M. Mills, MD, Cleveland, OH, USA
D.J. Moliterno, MD, Cleveland, OH, USA
F. Morady MD, Ann Arbor, MI, USA
D.A. Morrison, MD, Tucson, AZ, USA
A. Mugge, MD, Bochum, Germany
J.B. Muhlestein, MD, Salt Lake City, UT, USA
C.E. Mullins, MD, Houston, TX, USA
S.F. Nagueh, MD, Houston, TX, USA
P. Nihoyannopoulous, MD, London, United Kingdom
R.A. Nishimura, MD, Rochester, MN, USA
P.M. Okin, MD, New York, NY, USA
J.E. Olgin, MD, San Francisco, CA, USA
B. Olshansky, MD, Iowa City, IA, USA
M.F. O'Rourke, MD, Sydney, Australia
R.A. O'Rourke, MD, San Antonio, TX, USA
C.M. Otto, MD, Seattle, WA, USA
D.L. Packer, MD, Rochester, MN, USA
W. Palinski, MD, La Jolla, CA, USA
G.A. Pantely, MD, Portland, OR, USA
J.A. Panza, MD, Washington, DC, USA
D.J. Pennell, MD, London, United, Kingdom
W.F. Penny, MD, San Diego, CA, USA
K.L. Peterson, MD, San Diego, CA, USA
E. Picano, MD, Pisa, Italy
M.H. Picard, MD, Boston, MA, USA
B. Pitt, MD, Ann Arbor, MI, USA
P.A. Poole-Wilson, MD, London, United Kingdom
E.N. Prystowsky, MD, Indianapolis, IN, USA
K. Przyklenk, PhD, Worcester, MA, USA
M.A. Quinones, MD, Houston, TX, USA
S.H. Rahimtoola, MD, Los Angeles, CA, USA
R.F. Redberg, MD, MSc, San Francisco, CA, USA
N. Reichek, MD, Roslyn, NY, USA
S. Rich, MD, Skokie, IL, USA
R. Roberts, MD, Houston, TX, USA
K.A. Robinson, PhD, Norcross, GA, USA
R.J. Rodeheffer, MD, Rochester, MN, USA
S.A. Rubin, MD, Los Angeles, CA, USA
T.J. Ryan, MD, Boston, MA, USA
D.J. Sahn, MD, Portland, OR, USA
S. Sasayama, MD, Shizuoka, Japan
H.R. Schelbert, MD, PhD, Los Angeles, CA, USA
G. Schnyder, MD, Encinitas, Ca, USA
M. Schwaiger, MD, Muenchen, Germany
G.G. Schwartz, MD, PhD, Denver, CO, USA
D.S. Schwartzman, MD, Pittsburgh, PA, USA
P.W. Serruys, MD, Rotterdam, Netherlands
P.M. Shah, MD, Newport Beach, CA, USA
L.J. Shaw, PhD, Atlanta, GA, USA
M.A. Silver, MD, La Grange, IL, USA
N.H. Silverman, MD, Palo Alto, CA, USA
R.C. Starling, MD, MPH, Cleveland, OH, USA
C.I. Stefanadis, MD, Athens, Greece
W.G. Stevenson, MD, Boston, MA, USA
G.W. Stone, MD, New York, NY
B.H. Strauss, MD, PhD, Toronto, Canada
K. Sudhir, MBBS, South San Francisco, CA, USA
R.J. Sung, MD, Tainan, Taiwan
J.R. Teerlink, MD, San Francisco, CA, USA
J.M. Tobis, MD, Los Angeles, CA, USA
E.J. Topol, MD, Cleveland, OH, USA
J.A. Towbin, MD, Houston, TX, USA
Z.G. Turi, MD, Philadelphia, PA, USA
J.E. Udelson, MD, Boston, MA, USA
B.F. Uretsky, MD, Galveston, TX, USA
G.F. Van Hare, MD, Palo Alto, CA, USA
E.D. Verrier, MD, Seattle, WA, USA
G.W. Vetrovec, MD, Richmond, VA, USA
C.A. Visser, MD, Amsterdam, Netherlands
J.A. Vita, MD, Boston, MA, USA
R.E. Vlietstra, MB, ChB, Lakeland, FL, USA
R.A. Vogel, MD, Baltimore, MD, USA
F.J.Th. Wackers, MD, PhD, New Haven, CT, USA
K.T. Weber, MD, Memphis, TN, USA
S.L. Weinberg, MD, Dayton, OH, USA
W.S. Weintraub, MD, Atlanta, GA, USA
N.J. Weissman, MD, Washington, DC, USA
H.D. White, DSc, Auckland, New Zealand
D.J. Wilber, MD, Hinsdale, IL, USA
D.O. Williams, MD, Providence, RI, USA
R.F. Wilson, MD, Minneapolis, MN, USA
H. Wolinsky, MD, PhD, New York, NY, USA
M.A. Wood, MD, Richmond, VA, USA
A.C. Yeung, MD, Palo Alto, CA, USA
J. Yoshikawa, MD, Abeno-ku Osaka-shi Okaka, Japan
J.B. Young, MD, Cleveland, OH, USA
M.R. Zile, MD, Charleston, SC, USA
D.P. Zipes, MD, Indianapolis, IN, USA
|
